Precision Medicine in Pediatric Cancer

The Molenaar group aims to develop new treatment options for pediatric cancer. We do this by connecting basic biological research to immuno- as well as targeted therapies. New therapeutic options are eventually applied in clincal trials through our precision medicine program. Our translational work has a strong focus on neuroblastoma tumors.

Group members